Robert Mader, PhD

Toxicology Project Leader
F. Hoffmann-La Roche Ltd.
Basel

Presentation(s):

• Beyond the Conventional Paradigm: Rethinking the Necessity of Chronic Toxicity Studies for Biotherapeutics (S22)

  Wednesday, November 20, 2024
  3:45 PM - 5:00 PM CT

• Tick Box or Informing Patient Safety: Case Studies on the Value of Chronic Toxicity Studies for Biotherapeutics (S22-2)

  Wednesday, November 20, 2024
  4:05 PM - 4:25 PM CT